INVO Fertility (IVF) Cash from Investing Activities (2016 - 2025)
INVO Fertility (IVF) reported Cash from Investing Activities of -$8062.0 for Q3 2025, up 47.81% on a QoQ basis from -$15446.0 in Q2 2025.
INVO Fertility (IVF) has 9 years of Cash from Investing Activities data on file, last reported at -$8062.0 in Q3 2025.
- Quarterly Cash from Investing Activities changed N/A year-over-year to -$8062.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $354976.0 (up 8662.68% YoY) and the FY2024 annual result came in at $363895.0, up 114.59% from the prior year.
- Cash from Investing Activities climbed to -$8062.0 in Q3 2025 per IVF's latest filing, from -$15446.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $393134.0 in Q4 2024 and bottomed at -$2.3 million in Q3 2023.
- The 5-year median for Cash from Investing Activities is -$15048.0 (2025), against an average of -$244659.5.
- The widest annual swing landed in 2023, when Cash from Investing Activities slumped 74973.7%; it then surged 1080.94% in 2024.
- Tracing IVF's Cash from Investing Activities over 5 years: stood at -$917839.0 in 2021, then jumped by 100.94% to $8583.0 in 2022, then jumped by 287.86% to $33290.0 in 2023, then surged by 1080.94% to $393134.0 in 2024, then slumped by 102.05% to -$8062.0 in 2025.
- Per Business Quant, the three latest IVF Cash from Investing Activities figures stand at -$8062.0 (Q3 2025), -$15446.0 (Q2 2025), and -$14650.0 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -217.20 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 | -8,062.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -8,062.00 |
| Sep 30, 2025 | -8,062.00 |
| Jun 30, 2025 | -15,446.00 |
| Jun 30, 2025 | -15,446.00 |
| Mar 31, 2025 | -14,650.00 |
| Mar 31, 2025 | -14,650.00 |
| Dec 31, 2024 | 393,134.00 |
| Dec 31, 2024 | 393,134.00 |
| Jun 30, 2024 | -5,131.00 |
| Jun 30, 2024 | -5,131.00 |
| Mar 31, 2024 | -24,108.00 |
| Mar 31, 2024 | -24,108.00 |
| Dec 31, 2023 | 33,290.00 |
| Dec 31, 2023 | 33,290.00 |
| Sep 30, 2023 | -2.26 Mn |
| Sep 30, 2023 | -2.26 Mn |
| Jun 30, 2023 | -261,505.00 |
| Jun 30, 2023 | -261,505.00 |
| Mar 31, 2023 | -8,447.00 |
| Mar 31, 2023 | -8,447.00 |
| Dec 31, 2022 | 8,583.00 |
| Dec 31, 2022 | 8,583.00 |
| Sep 30, 2022 | -3,008.00 |
| Sep 30, 2022 | -3,008.00 |
| Jun 30, 2022 | -4,902.00 |
| Jun 30, 2022 | -4,902.00 |
| Mar 31, 2022 | -81,890.00 |
| Mar 31, 2022 | -81,890.00 |
| Dec 31, 2021 | -917,839.00 |
| Dec 31, 2021 | -917,839.00 |
| Sep 30, 2021 | -320,290.00 |
| Sep 30, 2021 | -320,290.00 |
| Jun 30, 2021 | -606,403.00 |
| Jun 30, 2021 | -606,403.00 |
| Mar 31, 2021 | -308,980.00 |
| Mar 31, 2021 | -308,980.00 |
| Dec 31, 2020 | -96,572.00 |
| Dec 31, 2020 | -96,572.00 |
| Sep 30, 2020 | -60,952.00 |
| Sep 30, 2020 | -60,952.00 |
| Jun 30, 2020 | -4,595.00 |
| Jun 30, 2020 | -4,595.00 |
| Mar 31, 2020 | -25,135.00 |
| Mar 31, 2020 | -25,135.00 |
| Sep 30, 2019 | -49,867.00 |
| Sep 30, 2019 | -49,867.00 |
| Jun 30, 2019 | -16,439.00 |
| Jun 30, 2019 | -16,439.00 |
| Mar 31, 2019 | -48,400.00 |
| Mar 31, 2019 | -48,400.00 |
| Dec 31, 2018 | -19,400.00 |
| Dec 31, 2018 | -19,400.00 |
| Dec 31, 2016 | -7,700.00 |
| Dec 31, 2016 | -7,700.00 |